| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |